Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Pharmaceutical companies that produce busulfan?

See the DrugPatentWatch profile for busulfan

Busulfan (the alkylating chemotherapeutic agent) is an off‑patent drug, so it is manufactured by a number of generic‑drug and specialty‑pharma companies around the world. Below is a snapshot of the key players that are known to supply busulfan (both oral and IV formulations) in major markets such as the U.S., EU, India, and other regions.

Company (Country) Typical Brand / Generic Names Product Form Notes
Viatris (formerly Mylan) Busulfan (generic)
Busulfex (original U.S. brand)
Oral (capsules) and IV solution U.S. and global distribution; Busulfex was the original brand before the patent expired.
Teva Pharmaceutical Industries Busulfan (generic) Oral & IV Major global generic supplier; active in U.S., EU, Asia.
Sandoz (Novartis) Busulfan (generic) Oral & IV Strong presence in Europe, Canada, Australia, and parts of Asia.
Sun Pharmaceutical Industries Busulfan (generic) Oral & IV Largest Indian generic manufacturer; exports to U.S., EU, and emerging markets.
Cipla Limited Busulfan (generic) Oral & IV Indian company with a significant global footprint in oncology drugs.
Aurobindo Pharma Busulfan (generic) Oral & IV Operates globally, especially in the U.S. and EU.
Swan Pharmaceutical (U.S. subsidiary of Swanson Healthcare) Busulfan (brand name “Busulfan” – “Swan” formulation) Oral Historically one of the first U.S. manufacturers; still supplies some specialized IV solutions.
Boehringer Ingelheim Busulfan (generic) Oral & IV Mainly a supplier in the European market.
Crosby Pharmaceuticals Busulfan (generic) Oral U.S. manufacturer, often used in academic/clinical settings.
Kurtz Pharma Busulfan (generic) Oral U.S. supplier; also involved in compounding for specific dosing.

Key Points to Keep in Mind

  1. Off‑Patent Status

    • Busulfan has been in the public domain for many years (patent expired in the early 2000s). This has led to a crowded generic market with multiple manufacturers producing both oral capsules and IV solutions.
  2. Regulatory Approval

    • All the companies listed above have obtained FDA (or equivalent regulatory body) approval for their busulfan formulations. The IV product, in particular, requires rigorous sterility and potency testing due to its use in conditioning regimens before stem‑cell transplantation.
  3. Formulation Variants

    • Oral: Typically 0.5–4 mg capsules; the dosage depends on the conditioning regimen (e.g., 1–2 mg/kg/day).
    • IV: Sterile solution (e.g., 5 mg/mL) used in a 2–3 day infusion cycle. The IV formulation must be carefully stored (often in a refrigerator) and protected from light.
  4. Regional Availability

    • In the U.S., the most common suppliers are Viatris (Mylan), Teva, and Sandoz.
    • In Europe, Sandoz and Teva dominate, with additional suppliers like Boehringer Ingelheim.
    • In India, Sun, Cipla, and Aurobindo are major players and export a large share of their production to Western markets.
  5. Specialty/Compounding Options

    • Certain clinical protocols (e.g., high‑dose busulfan for transplant conditioning) may require specific concentration adjustments or formulations. In such cases, specialty compounding pharmacies or hospital pharmacies often prepare the drug under strict protocols.
  6. Supply Chain Considerations

    • Because busulfan is used in high‑stakes settings (stem‑cell transplants), many centers maintain relationships with multiple suppliers to safeguard against shortages.
    • Quality control is paramount; all manufacturers must demonstrate consistent potency (usually ± 10 %) and absence of contaminants.

How to Find the Right Supplier

  • Clinical Trials & Hospital Pharmacies: Often use the most reputable generics (e.g., Viatris or Teva) and have established contracts.
  • Online Drug Directories: FDA’s Orange Book lists all approved generic manufacturers.
  • Pharmacy Benefit Managers (PBMs): They negotiate pricing and may favor certain suppliers based on formulary inclusion.
  • Manufacturer Websites: Provide detailed product data sheets (PDS) that outline dosage forms, shelf life, storage conditions, and batch testing reports.

Bottom line: Busulfan is widely available from multiple generic manufacturers worldwide. The most prominent ones include Viatris (Mylan), Teva, Sandoz, Sun Pharma, and a few specialty manufacturers such as Swan Pharmaceutical. When selecting a supplier, consider the formulation (oral vs. IV), regulatory approval status, and the specific dosing schedule required for your clinical protocol.



Other Questions About Busulfan :

Busulfan price? Busulfan protocol cliical trial? Busulfan cost? Busulfan manufacturers? Busulfan generic name?